Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LDHA | P00338 | 1/20 | 0.57 |
| ▸ | SRR | Q9GZT4 | 1/20 | 0.57 |
| ▸ | OR51E2 | Q9H255 | 3/20 | 0.50 |
| ▸ | EGLN1 | Q9GZT9 | 2/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | SLC13A3 | Q8WWT9 | 1/20 | 0.50 |
| ▸ | FEN1 | P39748 | 4/20 | 0.42 |
| ▸ | ERCC5 | P28715 | 3/20 | 0.42 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 3/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | HAO1 | Q9UJM8 | 3/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.38 |
| ▸ | SUCNR1 | Q9BXA5 | 1/20 | 0.38 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.35 |
| ▸ | GLRA1 | P23415 | 1/20 | 0.35 |
| ▸ | SLC6A9 | P48067 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Oxaloacetate SCHEMBL898612 | 1.00 | LDHA (0.57) | LDHASRROR51E2EGLN1MAPK1 | |
| Oxaloacetate SCHEMBL8464 | 1.00 | — | — | |
| Oxaloacetate SCHEMBL6545252 | 0.96 | LDHA (0.53) | LDHASRROR51E2EGLN1MAPK1 | |
| Oxaloacetate SCHEMBL20912993 | 0.96 | LDHA (0.53) | LDHASRROR51E2EGLN1MAPK1 | |
| Oxaloacetate SCHEMBL9994505 | 0.96 | LDHA (0.53) | LDHASRROR51E2EGLN1MAPK1 | |
| Oxaloacetate SCHEMBL25210523 | 0.96 | — | — | |
| Oxaloacetate SCHEMBL6545256 | 0.96 | LDHA (0.53) | LDHASRROR51E2EGLN1MAPK1 | |
| Oxaloacetate SCHEMBL9782818 | 0.96 | LDHA (0.53) | LDHASRROR51E2EGLN1MAPK1 | |
| Oxaloacetate SCHEMBL11328361 | 0.96 | LDHA (0.53) | LDHASRROR51E2EGLN1MAPK1 | |
| Oxaloacetate SCHEMBL8638879 | 0.96 | LDHA (0.53) | LDHASRROR51E2EGLN1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107602809-A | High-solid content water-based polyurethane dispersion liquid a kind of while based on aminocarboxylate and sulfamate | 温州大学 | 2018-01-19 | — | — | CN | claimed |
| CN-107223125-B | SGC stimulant | 赛科理音医疗有限公司 | 2019-09-27 | — | — | CN | disclosed |
| CN-109568496-A | The Chinese medicine composition treating the method for diabetes and using | 陈浩 | 2019-04-05 | — | — | CN | disclosed |
| CN-109486872-A | Stream plus the method for calcium agent in a kind of Citric Acid Fermentation | 日照金禾博源生化有限公司 | 2019-03-19 | — | — | CN | disclosed |
| CN-108853275-A | External Miao medicine liquid for repairing wound surface without leaving scar after healing and preparation method | 庞栋升 | 2018-11-23 | — | — | CN | disclosed |
| CN-108431014-A | Novel 5-azido-5-deoxy-2: 3-isopropylidene-D-arabinose compound, preparation method and application thereof in synthesizing ARA-N3, KDO-N3 and 4EKDO-N3 | 国家科研中心 | 2018-08-21 | — | — | CN | disclosed |
| CN-107296841-A | The antidepression prescription of unobstructed qi and blood | 合肥川迪医药技术有限公司 | 2017-10-27 | — | — | CN | disclosed |
| CN-107223125-A | SGC stimulants | 铁木医药有限公司 | 2017-09-29 | — | — | CN | disclosed |
| CN-104039977-B | Method for specifically marking live bacteria | 国家科学研究中心 | 2016-06-08 | — | — | CN | disclosed |
| CN-105063072-A | Aldolases, nucleic acids encoding them and methods for making and using them | VERENIUM CORP | 2015-11-18 | — | — | CN | disclosed |
| CN-101437954-A | Aldolases, nucleic acids encoding them and methods for making and using them | CARGILL INC (US) | 2009-05-20 | — | — | CN | disclosed |
| CN-101365787-A | Polypeptides and biosynthetic pathways for the production of stereoisomers of monatin and their precursors | CARGILL INC (US) | 2009-02-11 | — | — | CN | disclosed |
| CN-100444864-C | Chinese medicinal formulation for rehabilitating pancreatic islet function and decreasing blood sugar and preparation process thereof | YIREN MIAO (CN) | 2008-12-24 | — | — | CN | disclosed |
| CN-100387270-C | A Chinese medicinal preparation for treating and preventing diabetes and its angiopathy | SHANGHAI FANGXIN TECHNOLOGY IN (CN) | 2008-05-14 | — | — | CN | disclosed |
| CN-101115505-A | Methods and compositions for treating mammalian diseases and wounds caused by peroxynitrite overexpression | NORTH CELL PHARMACEUTICAL INC (US) | 2008-01-30 | — | — | CN | disclosed |
| CN-1317014-C | Soaking bath Chinese medicine for treating diabetes | HOU ZHENTAI (CN) | 2007-05-23 | — | — | CN | disclosed |
| CN-1768807-A | Chinese medicinal formulation for rehabilitating pancreatic islet function and decreasing blood sugar and preparation process thereof | MIAO YIREN (CN) | 2006-05-10 | — | — | CN | disclosed |
| CN-1759043-A | Safety containers for biologically active substances and method for producing said container | BAXTER HEALTHCARE SA (CH) | 2006-04-12 | — | — | CN | disclosed |
| CN-1754546-A | A Chinese medicinal preparation for treating and preventing diabetes and its angiopathy | SHANGHAI FANGXIN TECHNOLOGY IN (CN) | 2006-04-05 | — | — | CN | disclosed |
| CN-1709306-A | Soaking bath Chinese medicine for treating diabetes | HOU ZHENTAI (CN) | 2005-12-21 | — | — | CN | disclosed |